GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01548 GENSCRIPT BIO

Not Yet Opened 12-12 16:08:09

13.500

+0.140

+1.05%

High13.500	Low13.120	Vol11.16M
Open13.250	D1 Closing13.360	Amplitude2.84%
Mkt Cap29.51B	Tradable Cap29.51B	Total Shares2.19B
T/O149.06M	T/O Rate0.51%	Tradable Shares2.19B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01548","market":"HK","secType":"STK","nameCN":"GENSCRIPT BIO","latestPrice":13.5,"timestamp":1765526889003,"preClose":13.36,"halted":0,"volume":11155549,"delay":0,"floatShares":2186000000,"shares":2186000000,"eps":10.869343525949915,"marketStatus":"Not Yet Opened","change":0.14,"latestTime":"12-12 16:08:09","open":13.25,"high":13.5,"low":13.12,"amount":149064567,"amplitude":0.028443,"askPrice":13.5,"askSize":314000,"bidPrice":13.48,"bidSize":28000,"shortable":3,"etf":0,"ttmEps":10.944713877579618,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":0,"adr":0,"listingDate":1451404800000,"exchange":"SEHK","adjPreClose":13.36,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":0.7982305669787206,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01548","defaultTab":"news","newsList":[{"id":"1112969446","title":"HK Stock Movement | GENSCRIPT BIO (01548) Extends Losses by Over 11% in Afternoon Session as Affiliate Legend Biotech Drops 7% Overnight","url":"https://stock-news.laohu8.com/highlight/detail?id=1112969446","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112969446?lang=en_us&edition=fundamental","pubTime":"2025-12-09 14:04","pubTimestamp":1765260257,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) saw its afternoon losses widen by more than 11%, falling 11.07% to HK$13.41 by the time of writing, with a turnover of HK$307 million. The decline follows an overnight drop of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HK0000306701.USD","BK1576","HK0000306685.HKD","BK4585","BK1583","BK4505","01548","HK0000320223.HKD","BK4139","HK0000320264.USD","BK1141","LEGN"],"gpt_icon":0},{"id":"2589330034","title":"Legend Biotech Reports CARVYKTI® Delivers Median PFS of 50.4 Months in Multiple Myeloma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589330034","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589330034?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:30","pubTimestamp":1765197047,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8NvW69:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1576","HK0000320264.USD","HK0000306685.HKD","LEGN","01548","BK4585","BK4588","BK1583","HK0000306701.USD","HK0000320223.HKD","BK4505","BK1141"],"gpt_icon":0},{"id":"1160174342","title":"GENSCRIPT BIO (01548): Legend Announces Presentations at 2025 ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1160174342","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160174342?lang=en_us&edition=fundamental","pubTime":"2025-12-07 19:08","pubTimestamp":1765105695,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) announced that Legend Biotech (\"Legend,\" an associate company whose American Depositary Shares are listed on Nasdaq Global Select Market) issued a press release on December 6,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1583","ASH","HK0000306701.USD","HK0000320264.USD","LU2463526074.USD","BK1576","BK4109","HK0000306685.HKD","01548","HK0000320223.HKD"],"gpt_icon":0},{"id":"2589874315","title":"GenScript Affiliate Legend Biotech Showcases CAR-T Data at 2025 ASH Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589874315","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589874315?lang=en_us&edition=fundamental","pubTime":"2025-12-07 18:45","pubTimestamp":1765104329,"startTime":"0","endTime":"0","summary":"GenScript Biotech Affiliate Legend Biotech Presents New CAR-T Data at 2025 ASH Annual Meeting. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nNDL9T3z3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1141","HK0000306685.HKD","BK4588","HK0000320264.USD","BK4505","BK4139","BK1576","BK4585","HK0000306701.USD","01548","LEGN","HK0000320223.HKD"],"gpt_icon":0},{"id":"2589765821","title":"Legend Biotech Reports CARVYKTI Achieves 50.4-Month Median PFS in Multiple Myeloma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589765821","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589765821?lang=en_us&edition=fundamental","pubTime":"2025-12-07 03:00","pubTimestamp":1765047628,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation has announced new long-term clinical and translational data for its CARVYKTI  therapy from the CARTITUDE-1 and CARTITUDE-4 studies in patients with relapsed or refractory multiple myeloma. In triple-class-exposed patients who had received three prior lines of therapy, a median progression-free survival of 50.4 months was observed following a single infusion of CARVYKTI. Additionally, 80% of patients with standard-risk cytogenetics in the CARTITUDE-4 study remained progression-free and off treatment at 30 months after a single infusion. The results were presented at the American Society of Hematology  2025 annual meeting. Legend Biotech also presented first-in-human clinical data for its allogeneic CAR-T candidate LUCAR-G39D in adults with relapsed or refractory B-cell non-Hodgkin lymphoma. The study demonstrated a manageable safety profile and encouraging antitumor activity, with an overall response rate of 75% and a complete response rate of 37.5% among trea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nNDL4lzfb6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","NDAQ","LU2210150020.SGD","BK4505","HK0000306701.USD","IE00BKPKM429.USD","LU2095319765.USD","01548","BK1141","IE00B64PRP62.GBP","SG9999014005.SGD","LEGN","BK1576","IE00BGHQF748.EUR","HK0000306685.HKD","BK4585","BK4139","LU2210149790.SGD","HK0000320264.USD","BK4588","SG9999014013.SGD","BK4112","SG9999014021.USD","LU0314104364.USD","BK1583","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"1133471563","title":"Hong Kong Stocks Surge: CRO Concept Stocks Rally in Afternoon Session with WUXI BIO (02269) Up Over 7%; Analysts Highlight Industry Consolidation Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1133471563","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133471563?lang=en_us&edition=fundamental","pubTime":"2025-12-04 14:40","pubTimestamp":1764830440,"startTime":"0","endTime":"0","summary":"CRO concept stocks experienced a rapid surge in the afternoon session. As of press time, WUXI BIO (02269) rose 4.94% to HK$32.28, GENSCRIPT BIO (01548) gained 3.8% to HK$15.01, WUXI APPTEC (02359)...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0588546209.SGD","LU1046422090.SGD","LU0140636845.USD","BK1610","LU0823426480.USD","LU0516422366.SGD","02269","LU0359201612.USD","LU3063872942.SGD","IE00B0JY6N72.USD","BK1583","LU0417516902.SGD","LU0051755006.USD","03347","LU0819121731.USD","SG9999002463.SGD","LU0516423091.SGD","LU0516422952.EUR","LU1688375341.USD","LU0348825331.USD","LU1720050803.USD","HK0000306685.HKD","BK1141","LU0043850808.USD","LU0516423174.USD","HK0000306701.USD","LU1242518931.SGD","LU1242518857.USD","LU0039217434.USD","HK0000320223.HKD","BK1589","LU2039709279.SGD","LU2125910500.SGD","LU0417516738.SGD","LU0052750758.USD","BK1521","LU0979878070.USD","LU0327786744.USD","LU0359202008.SGD","LU0516422440.USD","LU0856984785.SGD","LU0456827905.SGD","LU0456846285.SGD","LU0348735423.USD","LU1794554557.SGD","SG9999002562.SGD","LU1880383366.USD","01548","LU0572944931.SGD","LU2242644610.SGD","02359","LU0320764599.SGD","LU0307460666.USD","LU0708995583.HKD","LU0181495838.USD","LU2045819591.USD","LU0326950275.SGD","LU0823426308.USD","HK0000320264.USD"],"gpt_icon":0},{"id":"1105023170","title":"Genscript Biotech (01548) Announces Monthly Return on Securities for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1105023170","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105023170?lang=en_us&edition=fundamental","pubTime":"2025-12-02 16:46","pubTimestamp":1764665169,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation (Stock Code: 01548) published the monthly return on movements in securities for the month ended 30 November 2025. The authorized share capital remained at USD 5,000,000,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"gpt_icon":0},{"id":"1189012034","title":"GTHT Maintains \"Overweight\" Rating on GENSCRIPT BIO (01548), Cites Innovation-Driven Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1189012034","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189012034?lang=en_us&edition=fundamental","pubTime":"2025-11-21 15:42","pubTimestamp":1763710950,"startTime":"0","endTime":"0","summary":"GTHT has reiterated its \"Overweight\" rating on GENSCRIPT BIO (01548), with a target price of HKD 26.21 per share. The company's core strategy revolves around \"technology-driven innovation\" and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","BK1147","HK0000306685.HKD","02611","HK0000306701.USD","HK0000320264.USD","BK1564","BK1576","BK1583","HK0000320223.HKD","BK1141"],"gpt_icon":0},{"id":"1150686106","title":"Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150686106","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150686106?lang=en_us&edition=fundamental","pubTime":"2025-11-21 14:52","pubTimestamp":1763707934,"startTime":"0","endTime":"0","summary":"CRO concept stocks experienced a collective decline in Hong Kong trading. As of press time, GENSCRIPT BIO (01548) dropped 6.05% to HKD 14.92, while PHARMARON (03759) fell 4.67% to HKD 20.8. VIVA...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300759","01548","HK0000306701.USD","BK1141","03347","BK0216","HK0000320264.USD","BK1576","03759","01873","HK0000320223.HKD","HK0000306685.HKD","BK1583"],"gpt_icon":0},{"id":"1117507033","title":"GENSCRIPT BIO (01548) Issues 489,600 Shares Under Restricted Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1117507033","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117507033?lang=en_us&edition=fundamental","pubTime":"2025-11-20 16:56","pubTimestamp":1763628976,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) announced that on November 20, 2025, it issued and allotted a total of 489,600 new shares under the Restricted Share Award Scheme adopted on August 23, 2021, and pursuant to the general mandate.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","HK0000320223.HKD","HK0000320264.USD","BK1576","BK1141","BK1583","HK0000306701.USD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2584816261","title":"GenScript Biotech Files HKEX Return for 13,142 New Shares Issued at HKD 0.00778 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2584816261","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584816261?lang=en_us&edition=fundamental","pubTime":"2025-11-20 16:51","pubTimestamp":1763628660,"startTime":"0","endTime":"0","summary":"GenScript Biotech Corporation has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, announcing the allotment and issue of 13,142 new shares on 20 November 2025 under its restricted share award scheme. The shares were issued at a price of HKD 0.00778 each.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief on November 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL4zgnfj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","HK0000320264.USD","BK1576","BK1583","HK0000306701.USD","01548","HK0000320223.HKD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2583369658","title":"Why Genscript Biotech (SEHK:1548) Is Up 8.0% After Legend Biotech’s CARVYKTI Drives Smaller Q3 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2583369658","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583369658?lang=en_us&edition=fundamental","pubTime":"2025-11-15 17:32","pubTimestamp":1763199121,"startTime":"0","endTime":"0","summary":"Earlier this week, Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, reported a significant reduction in net losses for the third quarter of 2025, alongside strong sales growth for its CARVYKTI product.\nThis disclosure, released around Genscript’s Analyst/Investor Day, places enhanced focus on the financial ties between the two companies and the implications for Genscript’s broader business outlook.\nWe’ll now explore how Legend Biotech’s improved...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/why-genscript-biotech-sehk1548-is-up-80-after-legend-biotech","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/why-genscript-biotech-sehk1548-is-up-80-after-legend-biotech","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1576","BK1583","01548","HK0000306701.USD","BK4588","BK4505","HK0000320264.USD","BK1141","HK0000306685.HKD","BK4139","BK4585","LEGN","HK0000320223.HKD"],"gpt_icon":0},{"id":"2583356810","title":"Genscript Biotech (SEHK:1548): Reviewing Valuation After Analyst and Investor Day Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583356810","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583356810?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:23","pubTimestamp":1763022214,"startTime":"0","endTime":"0","summary":"Genscript Biotech (SEHK:1548) just held its Analyst and Investor Day, a regular event where management updates shareholders on strategy and future plans. These sessions often spark renewed interest in the company’s growth prospects and valuation.\nSee our latest analysis for Genscript Biotech.\nFollowing the Analyst and Investor Day, Genscript Biotech’s shares surged with a 1-day share price return of 5.86 percent. This added to its strong year-to-date momentum and suggested renewed investor...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/genscript-biotech-sehk1548-reviewing-valuation-after-analyst","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/genscript-biotech-sehk1548-reviewing-valuation-after-analyst","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000320264.USD","01548","HK0000306701.USD","BK1583","BK1141","HK0000306685.HKD","BK1576","HK0000320223.HKD"],"gpt_icon":0},{"id":"1110735296","title":"HK Stock Movement | GENSCRIPT BIO (01548) Drops Over 4% as Associate Legend Biotech Reports Narrowed Q3 Net Loss of $39.7M","url":"https://stock-news.laohu8.com/highlight/detail?id=1110735296","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110735296?lang=en_us&edition=fundamental","pubTime":"2025-11-13 14:04","pubTimestamp":1763013858,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) fell more than 4% against the market trend, dropping 4.25% to HKD 16.43 by the time of writing, with a turnover of HKD 221 million. On the news front, on the evening of November...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01548","BK1576","HK0000306701.USD","LEGN","BK4585","BK1583","BK4505","BK4139","BK4588","HK0000320264.USD","HK0000320223.HKD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2582882376","title":"GenScript Biotech Affiliate Legend Biotech Reports Q3 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582882376","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582882376?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:29","pubTimestamp":1762950573,"startTime":"0","endTime":"0","summary":"GenScript Biotech Corporation announced the third quarter financial results for its affiliate, Legend Biotech Corporation. Legend Biotech is listed on the Nasdaq Global Select Market in the United States. The results pertain solely to Legend Biotech.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL8BTCfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK1576","HK0000306701.USD","01548","LEGN","BK4585","BK4588","HK0000320264.USD","BK1141","BK4139","HK0000320223.HKD","HK0000306685.HKD","BK1583"],"gpt_icon":0},{"id":"2582755023","title":"Legend Biotech Q3 revenue slightly misses estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582755023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582755023?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:11","pubTimestamp":1762949496,"startTime":"0","endTime":"0","summary":"Legend Biotech Q3 revenue slightly misses estimatesOverviewLegend Biotech Q3 revenue slightly misses analyst expectationsCollaboration revenue rises due to CARVYKTI sales under Janssen AgreementCompan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","HK0000306701.USD","BK4505","HK0000306685.HKD","HK0000320223.HKD","BK4588","BK4139","BK1576","01548","BK4585","BK1141","LEGN","HK0000320264.USD"],"gpt_icon":0},{"id":"2582876355","title":"Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876355","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582876355?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:34","pubTimestamp":1762778050,"startTime":"0","endTime":"0","summary":"Cabaletta Bio Inc. has appointed Steve Gavel as Chief Commercial Officer. Gavel previously led the launch and commercialization of CARVYKTI at Legend Biotech from 2018 to 2025. He will oversee global commercial strategy and execution for rese-cel and future pipeline opportunities at Cabaletta.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cabaletta Bio Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL5PrdCl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","BK4588","HK0000320223.HKD","CABA","LEGN","BK1576","HK0000306685.HKD","01548","BK1141","BK4585","BK4139","BK1583","BK4505","HK0000306701.USD"],"gpt_icon":0},{"id":"1123756471","title":"Genscript Biotech (01548) Announces Monthly Return for October 2025, Issued Shares Reach 2,185,678,939","url":"https://stock-news.laohu8.com/highlight/detail?id=1123756471","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123756471?lang=en_us&edition=fundamental","pubTime":"2025-11-04 16:22","pubTimestamp":1762244551,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation (01548) reported no changes in authorized share capital for October 2025, maintaining a total of 5,000,000,000 ordinary shares at a par value of USD 0.001 each,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"gpt_icon":0},{"id":"1110246984","title":"GENSCRIPT BIO (01548): Legend Biotech to Present Latest Data at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1110246984","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110246984?lang=en_us&edition=fundamental","pubTime":"2025-11-04 07:44","pubTimestamp":1762213449,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) announced that Legend Biotech Corporation (an associate company of GENSCRIPT BIO, whose shares are listed on the NASDAQ Global Select Market in the form of American Depositary...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01548","BK1576","HK0000306701.USD","BK1583","HK0000320264.USD","HK0000320223.HKD","HK0000306685.HKD"],"gpt_icon":0},{"id":"1143060404","title":"Genscript Biotech Corporation (1548) Announces Legend Biotech’s Data Presentation at 2025 ASH Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1143060404","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143060404?lang=en_us&edition=fundamental","pubTime":"2025-11-04 07:41","pubTimestamp":1762213266,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation (the Company), listed on the Hong Kong Stock Exchange under stock code 1548, issued a voluntary announcement regarding Legend Biotech Corporation (Legend), an associate...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genscript.com","stockEarnings":[{"period":"1week","weight":-0.1036},{"period":"1month","weight":-0.2133},{"period":"3month","weight":-0.2232},{"period":"6month","weight":-0.1687},{"period":"1year","weight":0.3261},{"period":"ytd","weight":0.372}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.003087},{"month":2,"riseRate":0.6,"avgChangeRate":0.090104},{"month":3,"riseRate":0.5,"avgChangeRate":-0.058342},{"month":4,"riseRate":0.5,"avgChangeRate":0.038375},{"month":5,"riseRate":0.5,"avgChangeRate":0.068155},{"month":6,"riseRate":0.6,"avgChangeRate":0.044564},{"month":7,"riseRate":0.6,"avgChangeRate":0.075818},{"month":8,"riseRate":0.4,"avgChangeRate":0.101263},{"month":9,"riseRate":0.4,"avgChangeRate":-0.071937},{"month":10,"riseRate":0.6,"avgChangeRate":0.095918},{"month":11,"riseRate":0.6,"avgChangeRate":0.045101},{"month":12,"riseRate":0.3,"avgChangeRate":0.04929}],"exchange":"SEHK","name":"GENSCRIPT BIO","nameEN":"GENSCRIPT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GENSCRIPT BIO(01548) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GENSCRIPT BIO,01548,GENSCRIPT BIO股票,GENSCRIPT BIO股票老虎,GENSCRIPT BIO股票老虎国际,GENSCRIPT BIO行情,GENSCRIPT BIO股票行情,GENSCRIPT BIO股价,GENSCRIPT BIO股市,GENSCRIPT BIO股票价格,GENSCRIPT BIO股票交易,GENSCRIPT BIO股票购买,GENSCRIPT BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GENSCRIPT BIO(01548) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}